What's new in DyslipidemiaLast update of the site: Tuesday March 19, 2019

I. Dicembrini et al. | Journal of Endocrinological Investigation...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are monoclonal antibodies, recently...
David A et al. | Pediatric Cardiology 2019; aop: 10.1007/s00246-019-02071-w...
Atherosclerosis promoting cardiovascular disease risk factors (CVDrf) are highly prevalent among children...
Sara Samadi et al. | Journal of Cellular Physiology 2019;...
Cardiovascular disease (CVD) is a major cause of morbidity and mortality, globally. The prevalence of...
Charlotte C. J. R. Michielsen et al. | Molecular Nutrition & Food Research...
Cardiovascular diseases (CVDs) are the main cause of death worldwide.1  The development of CVD and...
Christie M et al. | Cardiology and therapy 2019; aop: 10.1007/s40119-019-0131-8...
Fatty acids are an important energy substrate, but specific fatty acids also play consequential and distinct...
Federica Fogacci et al. | Phytotherapy Research 2019; AOP: 10.1002/ptr.6282...
Berberine (BBR) is a quaternary benzylisoquinoline alkaloid present in the root, rhizome, stem, fruit,...
R. Preston Mason et al. | Current atherosclerosis reports 2019;...
While statins have significantly reduced the global burden of atherosclerotic cardiovascular disease...
Shen, Yun Md et al. | Stroke 2019; 50(2): 291-7
Low level of HDL (high-density lipoprotein) cholesterol is a well-established risk factor for cardiovascular...
Ivo Petrov et al. | Advances in Therapy 2019; 36(3): 608-20...
Hyperlipidaemia is a major modifiable risk factor for the development of cardiovascular (CV) disease,...
Mathijs C et al. | Cardiology and therapy 2019; aop: 10.1007/s40119-019-0126-5...
In patients with ST-segment elevation myocardial infarction (STEMI), primary percutaneously coronary...

Bibliographical searchFocus and target to your research of scientific data

Research by journal
266 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

I. Dicembrini et al. | Journal of Endocrinological Investigation...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are monoclonal antibodies, recently introduced in the treatment of hypercholesterolemia for patients who do not achieve therapeutic targets...
Federica Fogacci et al. | Phytotherapy Research 2019; AOP: 10.1002/ptr.6282...
Berberine (BBR) is a quaternary benzylisoquinoline alkaloid present in the root, rhizome, stem, fruit, and bark of different species of plants as Coptis (Callosobruchus chinensis, japonica),...
R. Preston Mason et al. | Current atherosclerosis reports 2019;...
While statins have significantly reduced the global burden of atherosclerotic cardiovascular disease (ASCVD), there is still residual risk for clinical events among patients, such as those with type 2...
Ivo Petrov et al. | Advances in Therapy 2019; 36(3): 608-20...
Hyperlipidaemia is a major modifiable risk factor for the development of cardiovascular (CV) disease, the leading cause of death and disability in the developed world [1]. It is estimated that up to 50%...
Shen, Yun Md et al. | Stroke 2019; 50(2): 291-7
Low level of HDL (high-density lipoprotein) cholesterol is a well-established risk factor for cardiovascular diseases (CVD).1 A recent meta-analysis of individual data from 61 prospective studies found...